CSAN vs HP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CSAN exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While the company maintains strong liquidity (Current Ratio 2.58) and impressive operating margins (30.71%), these are completely offset by a negative net profit margin of -24.05% and a catastrophic YoY EPS decline of -712.5%. The stock is in a long-term technical downtrend, losing over 72% of its value over five years, and consistently misses earnings estimates. Despite a low Price/Sales ratio, the negative ROE and poor earnings quality make the current valuation risky.
HP presents a stark divergence between price action and fundamental performance. While the Piotroski F-Score of 5/9 indicates stable financial health and revenue growth is impressive at 50.2%, the company is suffering from a severe earnings collapse with YoY EPS growth of -121.1%. The stock is trading near its 52-week high despite negative profit margins and a prohibitively high PEG ratio of 6.81. Combined with bearish insider sentiment and a technical trend score of 10/100, the current valuation appears unsustainable.
Compare Another Pair
Related Comparisons
CSAN vs HP: Head-to-Head Comparison
This page compares Cosan S.A. (CSAN) and Helmerich & Payne, Inc. (HP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.